Enhanced Licensure Compact Legislation
Regulation of Medication Aides and the Enhanced Nursing Licensure Compact Get Hearings in Health Policy Committee
Representative Mary Whiteford, RN, has re-introduced the enhanced nursing licensure compact (eNLC) legislation. HB 4042 would join Michigan with other states participating in the eNLC to allow an RN to obtain a multi-state license and have privileges to practice in any other eNLC state without having to obtain licensure in each individual state. The bill would also authorize a nurse who holds a multi-state license to practice registered nursing or practical/vocational nursing in Michigan under the eNLC.
The bill was referred to the House Health Policy committee and had a hearing only on April 11, 2019. The National Council of State Boards of Nursing testified in support of the legislation. Several organizations support the bill such as ANA-MI, the Michigan Health and Hospital Association, and AARP.
Representative Ben Fredrick has re-introduced the medication aide legislation with some changes from last year’s bill. According to the legislative analysis, House Bill 4098 would allow for the training and permitting of medication aides, with conditions running parallel to the training and permitting of certified nurse aides (CNAs), which were adopted in 2017. Medication aide would mean a nurse aide who holds a registration to engage in practice as a medication aide.
Practice as a medication aide would be defined as administering regularly scheduled medications to residents of a nursing home or skilled nursing facility while under the supervision of a registered professional nurse. Practice as a medication aide would not include administering controlled substances or medications in injectable forms or the initial administration of medications or administration of “as needed” medication. A medication aide must first be registered and have practiced as a nurse aide, and must take a competency test upon completion of a state-approved medication aide program. The bill had a hearing only in House Health Policy committee on May 2, 2019. ANA-MI is neutral on the substitute version of the legislation.